Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Maja Bundalo, Sandra Vorlova, Jessica Ulrich, Giuseppe Rizzo, Elke Butt, Hendrik Bartolomaeus, Hla Ali, Ruggero Barbieri, Leon Richter, Leonie Höna, Manuel Egg, Julian Bock, Sarah Schäfer, Núria Amézaga Solé, Annabelle Rosa, Clément Cochain, Andreas Beilhack, Wolfgang Kastenmüller, Erik Henke, Boris V Skryabin, Timofey S Rozhdestvensky, Moritz Wildgruber, Kari Alitalo, Kristina Lorenz, Michaela Kuhn, Alma Zernecke
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Vasculogenesis
10.1146/annurev.cb.11.110195.000445 · 1995
Angiogenesis in health and disease
10.1038/nm0603-653 · 2003
Signal transduction by vascular endothelial growth factor receptors
10.1042/bj20110301 · 2011
The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation
10.1016/s0002-9440(10)63711-x · 2004
Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division
10.1182/blood.v99.7.2397 · 2002
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
10.1038/376066a0 · 1995
Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
10.1073/pnas.95.20.11709 · 1998
Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
10.1016/s0021-9258(18)47298-5 · 1994
Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases
10.1093/jb/mvs136 · 2013
Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
10.1073/pnas.95.16.9349 · 1998
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
10.1038/376062a0 · 1995
Alternative polyadenylation regulation in cardiac development and cardiovascular disease
10.1093/cvr/cvad014 · 2023
Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction
10.1016/j.amjcard.2009.07.016 · 2009
Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: the Dallas Heart Study
10.1016/j.atherosclerosis.2022.02.026 · 2022
Targeting cardiomyocyte ADAM10 ectodomain shedding promotes survival early after myocardial infarction
10.1038/s41467-022-35331-0 · 2022
The natriuretic peptide/guanylyl cyclase–a system functions as a stress-responsive regulator of angiogenesis in mice
10.1172/jci37430 · 2009
A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells
10.4049/jimmunol.144.2.521 · 1990
Cutadapt removes adapter sequences from high-throughput sequencing reads
2011
STAR: ultrafast universal RNA-seq aligner
10.1093/bioinformatics/bts635 · 2013
Twelve years of SAMtools and BCFtools
10.1093/gigascience/giab008 · 2021
PolyASite 2.0: a consolidated atlas of polyadenylation sites from 3′ end sequencing
2020
Integrative genomics viewer
10.1038/nbt.1754 · 2011
Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation
10.1016/j.molcel.2011.08.009 · 2011
Splicing mutations in human genetic disorders: examples, detection, and confirmation
10.1007/s13353-018-0444-7 · 2018
Mechanisms of angiogenesis and arteriogenesis
10.1038/74651 · 2000
Dynamics of monocyte-derived macrophage diversity in experimental myocardial infarction
10.1093/cvr/cvac113 · 2023
From remodeling to quiescence: the transformation of the vascular network
10.1016/j.cdev.2021.203735 · 2021
The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices
10.1074/mcp.m111.014647 · 2012
Full functional knockout of placental growth factor by knockin with an inactive variant able to heterodimerize with VEGF-A
10.1016/j.celrep.2018.05.067 · 2018
A heart-brain-spleen axis controls cardiac remodeling to hypertensive stress
10.1016/j.immuni.2025.02.013 · 2025
Transcription factors regulating vasculogenesis and angiogenesis
10.1002/dvdy.575 · 2024
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
10.1007/s00125-017-4322-3 · 2017
The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands
10.1126/scisignal.2003905 · 2013
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
10.1182/blood.v87.8.3336.bloodjournal8783336 · 1996
FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia
10.1038/s41598-017-11639-6 · 2017
Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span
10.1126/science.abc8479 · 2021
Elevated vascular endothelial growth factor receptor-2 abundance contributes to increased angiogenesis in vascular endothelial growth factor receptor-1-deficient mice
10.1161/circulationaha.112.091603 · 2012
The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching
10.1083/jcb.200709114 · 2008
Flt-1 (VEGFR-1) coordinates discrete stages of blood vessel formation
10.1093/cvr/cvw091 · 2016
VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment
10.1161/atvbaha.107.150433 · 2008
Alternative polyadenylation: new insights from global analyses
10.1261/rna.035899.112 · doi-reference
Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia
10.1016/j.cyto.2014.08.005 · doi-reference
Cardiovascular disease: new nanomedicines for treating atherosclerotic plaques
10.1038/nrendo.2015.35 · doi-reference
Reduction in insulin uncovers a novel effect of VEGFB on cardiac substrate utilization
10.1161/atvbaha.123.319972 · doi-reference
VEGFB/VEGFR1-induced expansion of adipose vasculature counteracts obesity and related metabolic complications
10.1016/j.cmet.2016.03.004 · doi-reference
Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue
10.1016/j.jhep.2023.01.014 · doi-reference
Susceptibility to cardiac arrhythmias and sympathetic nerve growth in VEGF-B overexpressing myocardium
10.1016/j.ymthe.2020.03.011 · doi-reference
Contribution of VEGF-B-induced endocardial endothelial cell lineage in physiological versus pathological cardiac hypertrophy
10.1161/circresaha.123.324136 · doi-reference
Endothelial cells regulate physiological cardiomyocyte growth via VEGFR2-mediated paracrine signaling
10.1161/circulationaha.118.036099 · doi-reference
Gene transfer as a tool to induce therapeutic vascular growth
10.1038/nm0603-694 · doi-reference
Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness
10.3892/ijo.2016.3362 · doi-reference
Predictive value of the sFlt-1/PlGF ratio in women with suspected preeclampsia: an update (review)
10.3892/ijmm.2023.5292 · doi-reference
Twist mechanics of the left ventricle: principles and application
10.1016/j.jcmg.2008.02.006 · doi-reference
Targeting immune-fibroblast cell communication in heart failure
10.1038/s41586-024-08008-5 · doi-reference
Myocardial fibrosis from the perspective of the extracellular matrix: mechanisms to clinical impact
10.1016/j.matbio.2024.08.008 · doi-reference
Cardiac fibroblastic niches in homeostasis and inflammation
10.1161/circresaha.124.323892 · doi-reference
VEGF-B promotes endocardium-derived coronary vessel development and cardiac regeneration
10.1161/circulationaha.120.050635 · doi-reference
VEGFA stop-gained variant deteriorates cardiac remodeling in myocardial infarction
10.1161/circgen.124.004879 · doi-reference
Angiogenesis after acute myocardial infarction
10.1093/cvr/cvaa287 · doi-reference
Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease
10.1038/ki.2013.339 · doi-reference
Suppressed production of soluble Fms-like tyrosine kinase-1 contributes to myocardial remodeling and heart failure
10.1161/hypertensionaha.116.07371 · doi-reference
The VEGF decoy receptor soluble Fms-like tyrosine kinase 1 binds to macrophages
10.1007/s10456-025-09980-w · doi-reference
Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment
10.1038/nm740 · doi-reference
Myeloid cell contributions to cardiovascular health and disease
10.1038/s41591-018-0064-0 · doi-reference
TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype
10.1182/blood-2007-08-108597 · doi-reference